Rob Lin

Company: Avista Therapeutics

Job title: Chief Executive Officer

Seminars:

Engineering Advanced Capsid Technologies to Overcome Ocular Barriers & Enhance Scalability 2:00 pm

Current vectors face the restriction of the blood-retinal-barriers when injecting into the eye. Therefore, the advancement of AI and large data provides efficient and creative way to pass through this boundary. This workshop examines engineered capsids using highthroughput multiplexing and machine learning approaches to achieve effective delivery at lower doses with reduced inflammatory responses. Key…Read more

day: Pre-Conference Workshop Day